Document is current
Any future updates will be listed below
-
Authors
Varble, Andrew http://orcid.org/0000-0002-4534-630X
Campisi, Edmondo
Euler, Chad W.
Maguin, Pascal
Kozlova, Albina
Fyodorova, Jessica http://orcid.org/0000-0002-5143-0145
Rostøl, Jakob T.
Fischetti, Vincent A.
Marraffini, Luciano A. http://orcid.org/0000-0002-9163-0969
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP1GM128184-01)
- License Information
-
More Information
Article History
Received: 28 January 2021
Accepted: 15 October 2021
First Online: 24 November 2021
Competing interests
: L.A.M. and A.V. are co-inventors on a patent application filed by The Rockefeller University relating to work in this study. L.A.M. is a founder and advisor of Intellia Therapeutics, Eligo Biosciences and CRISPR Biotechnologies. The remaining authors declare no competing interests.
